These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 39290859)
1. PLGA- Cao Q; Zhou R; Guo S; Meng K; Yang X; Liu M; Ma B; Su C; Duan X Int J Nanomedicine; 2024; 19():9437-9458. PubMed ID: 39290859 [TBL] [Abstract][Full Text] [Related]
2. pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity. Xu S; Wusiman A; Liu Z; Gu P; Ni H; Zhang Y; Hu Y; Liu J; Wu Y; Wang D Int J Biol Macromol; 2019 Mar; 125():865-875. PubMed ID: 30576729 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. Zheng J; Wang M; Pang L; Wang S; Kong Y; Zhu X; Zhou X; Wang X; Chen C; Ning H; Zhao W; Zhai W; Qi Y; Wu Y; Gao Y J Control Release; 2024 Sep; 373():568-582. PubMed ID: 39067792 [TBL] [Abstract][Full Text] [Related]
4. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines. Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438 [TBL] [Abstract][Full Text] [Related]
5. pH-responsive Astragalus polysaccharide-loaded PLGA nanoparticles as an adjuvant system to improve immune responses. Xu S; Feng Z; Zhang Y; Ni H; Liu Z; Wang D Int J Biol Macromol; 2022 Dec; 222(Pt B):1936-1947. PubMed ID: 36202333 [TBL] [Abstract][Full Text] [Related]
6. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. Wang Z; Miao F; Gu L; Zhang R; Ma Y; Li Y; Zheng J; Lin Z; Gao Y; Huang L; Shen Y; Wu T; Luo F; Li W ACS Nano; 2024 Sep; 18(35):24219-24235. PubMed ID: 39172516 [TBL] [Abstract][Full Text] [Related]
7. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8 Chen Q; Bao Y; Burner D; Kaushal S; Zhang Y; Mendoza T; Bouvet M; Ozkan C; Minev B; Ma W Drug Deliv Transl Res; 2019 Dec; 9(6):1095-1105. PubMed ID: 31228097 [TBL] [Abstract][Full Text] [Related]
8. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo. Sha X; Xu X; Liao S; Chen H; Rui W Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423 [TBL] [Abstract][Full Text] [Related]
9. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer. Sheikhzadeh S; Delirezh N; Hobbenaghi R Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752 [TBL] [Abstract][Full Text] [Related]
10. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response. Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734 [TBL] [Abstract][Full Text] [Related]
11. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442 [TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821 [TBL] [Abstract][Full Text] [Related]
13. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming. Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer. Xiong J; Jiang B; Luo Y; Zou J; Gao X; Xu D; Du Y; Hao L Int J Nanomedicine; 2020; 15():4151-4169. PubMed ID: 32606670 [TBL] [Abstract][Full Text] [Related]
15. Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice. Du X; Zhao B; Li J; Cao X; Diao M; Feng H; Chen X; Chen Z; Zeng X Int Immunopharmacol; 2012 Dec; 14(4):463-70. PubMed ID: 23006659 [TBL] [Abstract][Full Text] [Related]
16. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses. Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331 [TBL] [Abstract][Full Text] [Related]
17. Astragalus polysaccharide enhances antitumoral effects of chimeric antigen receptor- engineered (CAR) T cells by increasing CD122 Zhang Q; Su C; Luo Y; Zheng F; Liang CL; Chen Y; Liu H; Qiu F; Liu Y; Feng W; Dai Z Biomed Pharmacother; 2024 Oct; 179():117401. PubMed ID: 39243425 [TBL] [Abstract][Full Text] [Related]
18. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy. Kokate RA; Chaudhary P; Sun X; Thamake SI; Maji S; Chib R; Vishwanatha JK; Jones HP Nanomedicine (Lond); 2016; 11(5):479-94. PubMed ID: 26892440 [TBL] [Abstract][Full Text] [Related]
19. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination. Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487 [TBL] [Abstract][Full Text] [Related]
20. Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen. Hanlon DJ; Aldo PB; Devine L; Alvero AB; Engberg AK; Edelson R; Mor G Am J Reprod Immunol; 2011 Jun; 65(6):597-609. PubMed ID: 21241402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]